Empagliflozin mitigates cardiac hypertrophy through cardiac RSK/NHE-1 inhibition

Sha Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Coert J. Zuurbier(Amsterdam Neuroscience)
Biomedicine & Pharmacotherapy
March 24, 2024
Cited by 14


Related Papers